Trimeris Inc. (TRMS) Profile

Profile for Trimeris Inc. (TRMS)


Business Description: Synageva BioPharma Corp. is a biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Address:	128 Spring Street, Suite 520, Lexington, MA, 02421
Telephone:	(781) 357-9900	Website:	www.synageva.com
Facsimile:	(781) 357-9901	Email:	ir@synageva.com


Details

CEO:	Mr. Sanj K. Patel
Employees:	72	Market Cap:	53.8 m
Issue Type:	CS
Auditor:	Ernst & Young LLP
Last Audit:	Unqualified
Indices:	Biotechnology


Industry Classifications

Sector:	Healthcare	CIK:	0000911326
Industry:	Drugs
Sub-Industry:	Biotechnology
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Trimeris Inc.

Research stocks or mutual funds related to Trimeris Inc. by keywords or tags. Find companies that have a similar focus to TRMS. The keywords below have been associated to TRMS by either user submission or electronic means.

protease inhibitors biotech research pharmaceutical branding pharmaceutical industry strategy pharmaceutical publication pharmaceutical market Commercial Physical And Biological Research (8731) generic pharmaceutical pharmaceutical investment pharmaceutical patents pharmaceutical research and development trimeris pharmaceutical manufacturing company Biological Products pharmaceutical industry marketing pharmaceutical software pharma manufacturing tenofovir pharmaceutical supply chain novartis pharmaceuticals kv pharmaceutical company pharmaceutical cro viral diseases biopharmaceutical companies pharmaceutical sales pharma pharmaceutical distributors pharma in licensing pharmaceutical development pharmaceutical sales rep pharmaceutical reports biopharmaceutical company pharmaceutical production pharmaceutical consultant biotech pharmaceutical patent Drugs pharmaceutical auctions pharmaceutical translation pharmaceutical industry news pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation company research pharmaceutical article contract pharmaceutical pharmaceutical consulting pharmaceutical industry biotech industry

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.